Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.40 |
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | PRKCI | P41743 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | DRD5 | P21918 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1697250 | 0.83 | CYP3A4 (0.43) | CYP3A4ESR2ESR1ALDH1A1MAPT | |
| SCHEMBL10770264 | 0.79 | ESR2 (0.45) | CYP3A4ESR2ESR1ALDH1A1MAPT | |
| SCHEMBL6833886 | 0.78 | AHR (0.43) | MAPTRAB9AMAOB | |
| SCHEMBL30792604 | 0.75 | CYP3A4 (0.55) | CYP3A4ESR2ESR1ALDH1A1MAPT | |
| SCHEMBL11694183 | 0.74 | CA1 (0.40) | ALDH1A1MAPTDRD2CA2DRD3 | |
| SCHEMBL1383407 | 0.74 | GSK3B (0.31) | GSK3B | |
| SCHEMBL2809969 | 0.74 | GSK3B (0.33) | GSK3B | |
| SCHEMBL7158984 | 0.74 | LMNA (0.50) | CYP3A4ALDH1A1MAPTRAB9AHSD17B10 | |
| SCHEMBL11201231 | 0.74 | MMP12 (0.38) | ALDH1A1MAPTRAB9AHSD17B10GSK3B | |
| SCHEMBL5880944 | 0.74 | AHR (0.43) | CYP3A4MAPTCA2GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0594811-B1 | OXIDATION HAIR DYE BASED ON A CREAMY CARRIER AND PROCESS FOR DYEING HAIR | WELLA AG (DE) | 1996-06-12 | — | — | EP | claimed |
| EP-0375977-B1 | Oxidation hairdyeing composition based upon diaminopyrazole derivatives, and these diaminopyrazole derivatives | WELLA AG (DE) | 1994-02-02 | — | — | EP | claimed |
| EP-0460128-B1 | AGENT AND PROCESS FOR THE OXIDATIVE DYEING OF HAIR | Wella Aktiengesellschaft (DE) | 1993-06-09 | — | — | EP | claimed |
| EP-0241716-B1 | PROCESS AND COMPOSITION FOR OXIDATIVE HAIR DYEING | Wella Aktiengesellschaft (DE) | 1990-08-29 | — | — | EP | claimed |
| EP-0166100-B1 | OXIDATION HAIR-DYEING COMPOSITION BASED ON A LOW-VISCOSITY CARRIER | Wella Aktiengesellschaft (DE) | 1989-01-11 | — | — | EP | claimed |
| EP-0008080-B1 | HAIR DYEING COMPOSITION | Wella Aktiengesellschaft (DE) | 1981-07-01 | — | — | EP | claimed |
| WO-2025207688-A1 | DIBENZOFURAN PHOTOBASE GENERATORS FOR POLYIMIDE FORMATION | NITTO DENKO CORPORATION (US) | 2025-10-02 | — | — | WO | disclosed |
| US-12042480-B2 | Methods, agents, and compositions for the treatment of acute myeloid leukemia | UNIVERSITY OF CINCINNATI (US) | 2024-07-23 | — | — | US | disclosed |
| US-20230255906-A1 | Targeting Serpin B9 in Cancer | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2023-08-17 | — | — | US | disclosed |
| CN-114437008-B | Synthesis method of (R) -3-phenyl-3-hydroxymethyl-2, 3-dihydrobenzofuran compound | 常州大学 | 2023-07-25 | — | — | CN | disclosed |
| US-20220211669-A1 | Methods, Agents, and Compositions for the Treatment of Acute Myeloid Leukemia | UNIVERSITY OF CINCINNATI (US) | 2022-07-07 | — | — | US | disclosed |
| CN-114437008-A | Synthesis method of (R) -3-phenyl-3-hydroxymethyl-2, 3-dihydrobenzofuran compound | 常州大学 | 2022-05-06 | — | — | CN | disclosed |
| US-11311513-B2 | Methods, agents, and compositions for the treatment of acute myeloid leukemia | UNIVERSITY OF CINCINNATI (US) | 2022-04-26 | — | — | US | disclosed |
| WO-2002058658-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P&G - CLAIROL, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| US-5865856-A | MIXTURE CONTAINING COUPLER AND DEVELOPER | WELLA AKTIENGESELLSCHAFT (DE) | 1999-02-02 | — | — | US | disclosed |
| US-5480459-A | Oxidative hair dye based on a creamlike carrier composition as well as process for the dyeing of hair | WELLA AKTIENGESELLSCHAFT (DE) | 1996-01-02 | — | — | US | disclosed |
| US-4797130-A | DYE DEVELOPERS GOOD FOR RED COLORING | WELLA AKTIENGESELLSCHAFT (DE) | 1989-01-10 | — | — | US | disclosed |
| US-4713080-A | OXIDATIVE COLORING | WELLA AKTIENGESELLSCHAFT (DE) | 1987-12-15 | — | — | US | disclosed |
| US-4058607-A | DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES | AIRWICK INDUSTRIES, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-3962415-A | Insecticide evaporator comprising DDVP with synergized benzodioxole compound as stabilizer | AIRWICK INDUSTRIES, INC. (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11311513-B2 | Methods, agents, and compositions for the treatment of acute myeloid leukemia | TET1, TET2, TET3 | CYP3A4 2547/4885ESR2 2877/4885ESR1 3301/4885 |
| US-20220211669-A1 | Methods, Agents, and Compositions for the Treatment of Acute Myeloid Leukemia | TET1, TET2, TET3 | CYP3A4 2547/4885ESR2 2877/4885ESR1 3301/4885 |
| US-12042480-B2 | Methods, agents, and compositions for the treatment of acute myeloid leukemia | TET1, TET2, TET3 | CYP3A4 2547/4885ESR2 2877/4885ESR1 3301/4885 |
| US-20230255906-A1 | Targeting Serpin B9 in Cancer | SERPINB10, SERPINB8, SERPINE1 | CYP3A4 3222/4885ESR2 1341/4885ESR1 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.